Literature DB >> 3773965

The prevalence of cancer. Estimates based on the Connecticut Tumor Registry.

A R Feldman, L Kessler, M H Myers, M D Naughton.   

Abstract

Cancer incidence and mortality do not fully reflect the effect of cancer. To estimate the number of persons alive who have a history of cancer, we derived prevalence rates based on data from the Connecticut Tumor Registry. We did not attempt to distinguish between people who had been cured of cancer and those who still had the disease. In 1982 the age-adjusted prevalence rates of cancer among males and females were 1,789 and 2,222, respectively, per 100,000. Age-specific prevalence rates were highest among the elderly; 12 percent of men and 11 percent of women over 70 had previously been given a diagnosis of cancer. Breast cancer in females and prostate cancer in males were the two most prevalent malignant diseases. We estimate that about 5 million persons alive in the United States today have at one time received a diagnosis of cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3773965     DOI: 10.1056/NEJM198611273152206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes.

Authors:  K L Mohn; T M Laz; J C Hsu; A E Melby; R Bravo; R Taub
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

3.  Breast cancer incidence and prevalence estimated from survival and mortality.

Authors:  R Capocaccia; A Verdecchia; A Micheli; M Sant; G Gatta; F Berrino
Journal:  Cancer Causes Control       Date:  1990-07       Impact factor: 2.506

4.  Risk-adjusted cancer-incidence rates (United States).

Authors:  R M Merrill; E J Feuer
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

5.  Screening prospective blood donors for AIDS risk factors: will sufficient donors be found?

Authors:  D I Gregorio; J V Linden
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

6.  Prevalence of thyroid nodules and carcinomas in patients operated on for renal hyperparathyroidism: experience with 339 consecutive patients and review of the literature.

Authors:  Daniel Seehofer; Nada Rayes; Jochen Klupp; Natascha C Nüssler; Frank Ulrich; Klaus-Jürgen Graef; Ralph Schindler; Thomas Steinmüller; Ulrich Frei; Peter Neuhaus
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

7.  Survivors of childhood cancer in the United States: prevalence and burden of morbidity.

Authors:  Siobhan M Phillips; Lynne S Padgett; Wendy M Leisenring; Kayla K Stratton; Ken Bishop; Kevin R Krull; Catherine M Alfano; Todd M Gibson; Janet S de Moor; Danielle Blanch Hartigan; Gregory T Armstrong; Leslie L Robison; Julia H Rowland; Kevin C Oeffinger; Angela B Mariotto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04       Impact factor: 4.254

8.  [Prevalence of cancer in the Guadalajara health area].

Authors:  J M Alonso Gordo; A Bárcena Marugán; D Jiménez Del Val; J J Palacios Rojo; C Royo Sánchez; J Urbina Torija
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 9.  Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.

Authors:  J P Crew; T S O'Brien; A L Harris
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

10.  Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden.

Authors:  R M Merrill
Journal:  J Epidemiol Community Health       Date:  2001-03       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.